These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3050182)

  • 21. Therapeutic evaluation of the ticarcillin-clavulanic acid combination in severe nephrourologic infections.
    Dalet F; Torrellas A; Del Rio G
    Chemioterapia; 1987 Jun; 6(2 Suppl):512-3. PubMed ID: 3509486
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
    Sanders CV; Aldridge KE
    J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of timentin.
    Thomas MG; Lang SD
    N Z Med J; 1985 May; 98(779):403-4. PubMed ID: 3857527
    [No Abstract]   [Full Text] [Related]  

  • 24. Timentin in the treatment of invasive burn wound infection with sepsis.
    Diem E; Graninger W
    J Antimicrob Chemother; 1986 May; 17 Suppl C():123-6. PubMed ID: 3636327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
    Reed MD
    Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clavulanic acid/antibiotic ratios.
    Rolinson GN
    J Antimicrob Chemother; 1985 Feb; 15(2):256-7. PubMed ID: 3980316
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of ticarcillin/clavulanate on the intestinal microflora.
    Nord CE; Bergan T; Thorsteinsson SB
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():221-6. PubMed ID: 2606816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F; Li J; Gao L; Chen Y
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
    de Barbeyrac B; Quentin C; Bebear C
    Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
    Itokazu GS; Danziger LH
    Pharmacotherapy; 1991; 11(5):382-414. PubMed ID: 1745624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity and disk susceptibility of Timentin: current status.
    Fuchs PC; Barry AL; Jones RN
    Am J Med; 1985 Nov; 79(5B):25-32. PubMed ID: 4073092
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antimicrobial activities of clavulanic acid/ticarcillin against clinical isolates].
    Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Dec; 48(12):1899-905. PubMed ID: 8587164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timentin in the antimicrobial treatment of nosocomial and polymicrobial infections.
    Carlet J; Goldstein FW; Blériot JP; Bahloul F; Dazza FE
    J Antimicrob Chemother; 1986 May; 17 Suppl C():149-59. PubMed ID: 3636330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of the combination of Timentin and tobramycin in the treatment of patients with bacteraemia.
    Degener JE; Wagenvoort JH; Dzoljic-Danilovic G; Michel MF; Brus-Weijer A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():141-8. PubMed ID: 3636329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid.
    Casal MJ; Rodriguez FC; Luna MD; Benavente MC
    Antimicrob Agents Chemother; 1987 Jan; 31(1):132-3. PubMed ID: 3105441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timentin in the treatment of post-operative infections.
    McLatchie GR; Williams S; Parameswaran S; Lindsay G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():189-94. PubMed ID: 3636333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ticarcillin for treatment of serious infections with gram-negative bacteria.
    Parry MG; Neu HC
    J Infect Dis; 1976 Nov; 134(5):476-85. PubMed ID: 825582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.